LatchBio tested the currently served version of Grok 4.6 across its full suite of biological-capability evaluations, including BioSecBench-Refusal.
Public source
Publisher name
Public post
Following the initial release of Grok 4.6, LatchBio tested the currently-served version of the model across our full suite of biological-capability evaluations, includin…
Company
LatchBio
Agent Infrastructure for Biology
- Industry
- Biotechnology Research
- Location
- San Francisco, US
- Company size
- 51–200 employees
About LatchBio
Agent infrastructure for biology. Bundled with kits + machines to serve 300+ pharma, biotech and academic teams around the world.
See moreLatest activity
Latest activity from LatchBio
10 signals
People
LatchBio is hiring a new designer named Nathan to join the team.
People
LatchBio is excited to work with Nathan Manske to build out the design team.
Presence & Recognition
LatchBio accepted research submissions for the 2026 NeurIPS workshop in Paris, France titled AIDaR: Data Infrastructure and Benchmarks for Reliable Scientific AI Systems.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
SpaceXAI
SpaceXAI evaluated Grok 4.6's performance on biosecurity monitoring and adversarial biological tasks, finding it correctly detects and refuses dangerous queries, including maliciously obfuscated biological tasks, while allowing beneficial scientific queries to be answered.
Research & Knowledge
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. ran experiments to evaluate how well local AI models could review a synthetic GxP audit trail, including scoring against a matched random baseline.
Research & Knowledge
Kantify
Kantify validated Sapian's ability to generalize across different target classes, both in vitro and in vivo, from human health to crop science.
Research & Knowledge
RECEPTOR.AI
RECEPTOR.AI is finalizing an upcoming whitepaper featuring internal benchmark results demonstrating the capabilities of ForceFold, a co-folding architecture conditioned by physics-based methods.
Research & Knowledge
Terns Pharmaceuticals